FDA announces recall of Rohto eye drops due to sterility concerns

The U.S. Food and Drug Administration has issued a Class II recall for nearly 12 million bottles of Rohto Cooling Eye Drops. The recall, initiated by Rohto-Mentholatum, is due to a lack of sterility assurance, raising concerns about potential eye infections for consumers. This action covers eight product configurations distributed nationwide.